_________
false
קומפיוגן בע"מ
2
380
COMPUGEN LTD
Corporation no:
511779639
10690
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
20/09/2018
www.isa.gov.il
www.tase.co.il
Reference:
2018-02-085213
Time of broadcast:
12:27
12:25:24
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
Delay the publication of a report
20/09/2018
13:57
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration with Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial
6k_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
TASE
Date of revision of form structure:
04/09/2018
Address:
Harokmim
26
,
Holon
5885849
,
Israel
Tel:
03-7658585
,
03-7658525
Fax:
03-7658555
E-mail address:
donnag@cgen.com
Previous names of reporting entity:
Name of the Signatory:
Gershowitz Donna Lynn
Position of Signatory in the reporting corporation:
General Counsel
Name of Employer Company:
Address:
Harokmim Street
26
,
Holon
5885849
Telephone:
03-7658585
Facsimile:
03-7658555
E-mail:
Donnag@cgen.com
1
Israel